| Dr Emad Nourollah-zadeh, MD | |
|
Robert Wood Johnson University Hospital, 125 Paterson Street,, New Brunswick, NJ 08901 | |
| (732) 235-7041 | |
| Not Available |
| Full Name | Dr Emad Nourollah-zadeh |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 14 Years |
| Location | Robert Wood Johnson University Hospital, New Brunswick, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164734687 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Robert Wood Johnson University Hospital | New brunswick, NJ | Hospital |
| Community Medical Center | Toms river, NJ | Hospital |
| Robert Wood Johnson University Hospital - Somerset | Somerville, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rutgers Health-rwj Neurosurgery Faculty | 4587613443 | 95 |
News Archive
Eli Lilly and Company will halt development of semagacestat, a gamma secretase inhibitor being studied as a potential treatment for Alzheimer's disease, because preliminary results from two ongoing long-term Phase III studies showed it did not slow disease progression and was associated with worsening of clinical measures of cognition and the ability to perform activities of daily living.
Pritzker Olsen law firm has been retained to represent a 3-year-old child sickened with an E. coli O157:H7 infection and hemolytic uremic syndrome. The child is believed to have contracted the illness at a local apple orchard/ petting zoo in the Twin Cities (MN) area. Preliminary testing indicates that the genetic fingerprint of the E .coli O157:H7 obtained from the child's stool sample matches the genetic fingerprint of E. coli from llama feces tested at the petting zoo.
Threshold Pharmaceuticals, Inc. today announced interim results from an ongoing Phase 1/2 clinical trial in various solid tumors related to its hypoxia-activated prodrug, TH-302. The results were presented at the European Society for Medical Oncology (ESMO) Annual Meeting being held in Milan, Italy.
The Scripps Research Institute has been awarded a $2.2 million grant from the National Institutes of Health (NIH) to develop novel therapeutics for the treatment of addiction to multiple substances in a national effort with the University of Kansas.
A collaborative study between The University of Auckland and the Fiji School of Medicine documenting the scale and nature of traffic injury in Pacific Island nations could help minimise death on the roads.
› Verified 6 days ago
| Entity Name | Rutgers Health-rwj Neurology Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366487183 PECOS PAC ID: 2860485141 Enrollment ID: O20040405000110 |
News Archive
Eli Lilly and Company will halt development of semagacestat, a gamma secretase inhibitor being studied as a potential treatment for Alzheimer's disease, because preliminary results from two ongoing long-term Phase III studies showed it did not slow disease progression and was associated with worsening of clinical measures of cognition and the ability to perform activities of daily living.
Pritzker Olsen law firm has been retained to represent a 3-year-old child sickened with an E. coli O157:H7 infection and hemolytic uremic syndrome. The child is believed to have contracted the illness at a local apple orchard/ petting zoo in the Twin Cities (MN) area. Preliminary testing indicates that the genetic fingerprint of the E .coli O157:H7 obtained from the child's stool sample matches the genetic fingerprint of E. coli from llama feces tested at the petting zoo.
Threshold Pharmaceuticals, Inc. today announced interim results from an ongoing Phase 1/2 clinical trial in various solid tumors related to its hypoxia-activated prodrug, TH-302. The results were presented at the European Society for Medical Oncology (ESMO) Annual Meeting being held in Milan, Italy.
The Scripps Research Institute has been awarded a $2.2 million grant from the National Institutes of Health (NIH) to develop novel therapeutics for the treatment of addiction to multiple substances in a national effort with the University of Kansas.
A collaborative study between The University of Auckland and the Fiji School of Medicine documenting the scale and nature of traffic injury in Pacific Island nations could help minimise death on the roads.
› Verified 6 days ago
| Entity Name | Rutgers Health-rwj Neurosurgery Faculty |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083738637 PECOS PAC ID: 4587613443 Enrollment ID: O20050118000611 |
News Archive
Eli Lilly and Company will halt development of semagacestat, a gamma secretase inhibitor being studied as a potential treatment for Alzheimer's disease, because preliminary results from two ongoing long-term Phase III studies showed it did not slow disease progression and was associated with worsening of clinical measures of cognition and the ability to perform activities of daily living.
Pritzker Olsen law firm has been retained to represent a 3-year-old child sickened with an E. coli O157:H7 infection and hemolytic uremic syndrome. The child is believed to have contracted the illness at a local apple orchard/ petting zoo in the Twin Cities (MN) area. Preliminary testing indicates that the genetic fingerprint of the E .coli O157:H7 obtained from the child's stool sample matches the genetic fingerprint of E. coli from llama feces tested at the petting zoo.
Threshold Pharmaceuticals, Inc. today announced interim results from an ongoing Phase 1/2 clinical trial in various solid tumors related to its hypoxia-activated prodrug, TH-302. The results were presented at the European Society for Medical Oncology (ESMO) Annual Meeting being held in Milan, Italy.
The Scripps Research Institute has been awarded a $2.2 million grant from the National Institutes of Health (NIH) to develop novel therapeutics for the treatment of addiction to multiple substances in a national effort with the University of Kansas.
A collaborative study between The University of Auckland and the Fiji School of Medicine documenting the scale and nature of traffic injury in Pacific Island nations could help minimise death on the roads.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Emad Nourollah-zadeh, MD 125 Paterson St Ste 6200, New Brunswick, NJ 08901-1962 Ph: (732) 235-3288 | Dr Emad Nourollah-zadeh, MD Robert Wood Johnson University Hospital, 125 Paterson Street,, New Brunswick, NJ 08901 Ph: (732) 235-7041 |
News Archive
Eli Lilly and Company will halt development of semagacestat, a gamma secretase inhibitor being studied as a potential treatment for Alzheimer's disease, because preliminary results from two ongoing long-term Phase III studies showed it did not slow disease progression and was associated with worsening of clinical measures of cognition and the ability to perform activities of daily living.
Pritzker Olsen law firm has been retained to represent a 3-year-old child sickened with an E. coli O157:H7 infection and hemolytic uremic syndrome. The child is believed to have contracted the illness at a local apple orchard/ petting zoo in the Twin Cities (MN) area. Preliminary testing indicates that the genetic fingerprint of the E .coli O157:H7 obtained from the child's stool sample matches the genetic fingerprint of E. coli from llama feces tested at the petting zoo.
Threshold Pharmaceuticals, Inc. today announced interim results from an ongoing Phase 1/2 clinical trial in various solid tumors related to its hypoxia-activated prodrug, TH-302. The results were presented at the European Society for Medical Oncology (ESMO) Annual Meeting being held in Milan, Italy.
The Scripps Research Institute has been awarded a $2.2 million grant from the National Institutes of Health (NIH) to develop novel therapeutics for the treatment of addiction to multiple substances in a national effort with the University of Kansas.
A collaborative study between The University of Auckland and the Fiji School of Medicine documenting the scale and nature of traffic injury in Pacific Island nations could help minimise death on the roads.
› Verified 6 days ago
Huong Truong, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901 Phone: 480-452-4711 | |
Gustavo Bauza, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 125 Paterson Street Suite 6300, Robert Wood Johnson Medical School Division Of Acs, New Brunswick, NJ 08901 Phone: 732-235-7766 | |
Dr. Marc William Lafonte, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901 Phone: 732-828-3000 | |
Albert Assad, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 254 Easton Ave, New Brunswick, NJ 08901 Phone: 732-745-8571 Fax: 732-249-5284 | |
Dr. Jennifer To, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 125 Paterson St Ste 6300, New Brunswick, NJ 08901 Phone: 732-235-7766 Fax: 732-235-2964 | |
Dr. Georg N Herlitz, MD Surgery Medicare: Medicare Enrolled Practice Location: 125 Paterson St, Clinical Academic Building, Dept Of Surgery, New Brunswick, NJ 08901 Phone: 646-382-2730 | |
Victoria Needham, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 125 Paterson St Ste 4100, New Brunswick, NJ 08901 Phone: 732-235-7920 |